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Table 1: Phenotypic identification of the suspected C. difficile colonies extracted from
contaminated gowns.
Figure 3: Life cycle of C. difficile in the gut. (A) toxigenic C. difficile may be present in healthy human
microbiota.(B) dysbiosis occurs (e.g. due to antibiotics) which allows for colonisation of C. difficile.
(C) C. difficile toxins lead to inflammation of the distal gut and thus C. difficile mediated disease [5]
• It was concluded that the surgical gowns from Rideout Hospital, USA, were 
contaminated with C. difficile. 
• Future work will include conformational testing of all presumptive C. difficile
strains at the National Anaerobic reference Unit, Cardiff, UK,.
• Implications include gowns acting as fomites and the need to dispose of 
gowns immediately after use to prevent spore transfer
• Biocide testing will establish if current infection control measures and 
disinfectants (sporicides) are working. 
• This work aims  to limit  the prevalence of spores and spread of 
infection in hospitals. 
Conclusions and Future Work
Introduction
Clostridium difficile is a Gram-positive, spore-forming anaerobe that
comprise either toxigenic or non-toxigenic strains. Toxigenic C. difficile
usually possess Toxin A (TcdA) and Toxin B (TcdB); although some strains
can be variant [1]. C. difficile can exist in vegetative bacterial form or as
metabolically dormant, highly disinfectant resistant spores.
Spores can attach to clinical surfaces for months via structures such as the
exosporium and are implicated in organism transmission [2]. C. difficile
infection (CDI) is the leading cause of antibiotic-and healthcare-associated
diarrhoea globally [3]. One reason for high incidence rates is due to the
adherence of spores to surgical gowns which can ‘trap’ the spores and
transfer them to stainless steel surfaces and hospital floor vinyl [4].
Figure 1: Spore surface of a C. difficile clinical 
isolate. SEM image [1]
Figure 2: Spore surface of a C. difficile clinical 
isolate. SEM image [4] 
Aim of Study
To determine whether C. difficile can be isolated from “used” hospital 
gowns. Any presumptive C. difficile will also be identified.
Methods
• “Used” hospital gowns were suspended in 15ml degassed Brain Heart Infusion
broth + 0.1% Sodium Taurocholate (BHIST) and vortex mixed to dislodge bacteria.
Broth was incubated for 3d anaerobically (37oC) and then 4oC o/n to encourage
sporulation. C. difficile strains DS1813, DS1748, R2021 were positive controls
• Broth was centrifuged at x5000g and resuspended in sterile BHIST. 100ul was
spread onto C. difficile selective agar and incubated anaerobically 37oC, 48h.
Resulting colonies were analysed for characteristic C. difficile colony morphology
(Fig ). Presumptive colonies were streaked onto degassed BHIST agar at 37oC, 48h.
• CDIFF QUIK CHEK COMPLETE® (TECHLAB) was used to identify C. difficile from
presumptive colonies. Each sample was examined for the production of glutamate
dehydrogenase (GDH) and toxins A/B. (n=2).
• DNA Extraction: 0.2g Chelex 100 Resin was added to 4ml sterile deionized water
and vortexed. 100µl was added to a loop of C. difficile in an Eppendorf, and heated
to >90oC/12 min. Samples were centrifuged at x8000g/12min and supernatant was
used as DNA extract. All samples were analysed using 16S-23S and toxin PCR
Figure 4: Colonies of C. difficile
CD630 on degassed BHI agar.
Figure 5 : Suspected C. 
difficile on BHIST agar. 
Figure 6 : Suspected C. difficile 
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• 23 colonies were isolated from the gowns. After phenotypic analysis (Table 1)
only 8 isolates showed characteristic C. difficile growth. CDIFF QUIK CHEK
COMPLETE® (TECHLAB) analysis confirmed these results (Figure ).
• After PCR analysis via 16S-23SrRNA inter-spacer region [6] and toxin A and
toxin B PCR [7], this was reduced to 5 final samples which are presumed to be
C. difficile.
• These samples are currently undergoing final confirmatory testing at the
National Anaerobic Reference unit, Cardiff, UK.
Figures A, B and C: A shows a full positive result on the C.DIFF QUIK CHEK; B shows a
negative result and C shows a result positive for the antigen but negative for toxin A/B.
A B C
Figure: Detection of 16s-23s rRNA intergenic spacer region. M represents 1Kb Plus DNA
Ladder marker, Lane 1 = control strain DS1813, lane 2 = control strain R20291, lane 3 =
control strain DS1748, lane 4 = sample 7, lane 5 = sample 8, lane 6 = sample 9, lane 7 = Non
toxigenic control DS1684 and lane 8 = negative control. Samples are shown in Table 1.
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